| H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks TM Marti, E Hefner, L Feeney, V Natale, JE Cleaver Proceedings of the National Academy of Sciences 103 (26), 9891-9896, 2006 | 419 | 2006 |
| DNA mismatch repair and mutation avoidance pathways TM Marti, C Kunz, O Fleck Journal of cellular physiology 191 (1), 28-41, 2002 | 372 | 2002 |
| Isolation, characterization and amino‐acid sequence of γ‐seminoprotein, a glycoprotein from human seminal plasma J Schaller, K Akiyama, R Tsuda, M Hara, T Marti, EE Rickli European journal of biochemistry 170 (1‐2), 111-120, 1987 | 184 | 1987 |
| Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin Y Shi, E Felley-Bosco, TM Marti, K Orlowski, M Pruschy, RA Stahel BMC cancer 12, 1-10, 2012 | 144 | 2012 |
| A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids J Ruppen, L Cortes-Dericks, E Marconi, G Karoubi, RA Schmid, R Peng, ... Lab on a Chip 14 (6), 1198-1205, 2014 | 138 | 2014 |
| Complete amino acid sequence of human plasma Zn-alpha 2-glycoprotein and its homology to histocompatibility antigens. T Araki, F Gejyo, K Takagaki, H Haupt, HG Schwick, W Bürgi, T Marti, ... Proceedings of the National Academy of Sciences 85 (3), 679-683, 1988 | 135 | 1988 |
| The complete amino acid sequence of the A-chain of human plasma alpha 2HS-glycoprotein. Y Yoshioka, F Gejyo, T Marti, EE Rickli, W Bürgi, GD Offner, RF Troxler, ... Journal of Biological Chemistry 261 (4), 1665-1676, 1986 | 112 | 1986 |
| Translesion DNA synthesis in the context of cancer research PA Knobel, TM Marti Cancer cell international 11, 1-19, 2011 | 109 | 2011 |
| DNA repair nucleases TM Marti, O Fleck Cellular and Molecular Life Sciences CMLS 61, 336-354, 2004 | 103 | 2004 |
| Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer SQ Liang, TM Marti, P Dorn, L Froment, SRR Hall, S Berezowska, ... Cell death & disease 6 (7), e1824-e1824, 2015 | 91 | 2015 |
| Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin LL Belyanskaya, TM Marti, S Hopkins-Donaldson, S Kurtz, E Felley-Bosco, ... Molecular cancer 6, 1-13, 2007 | 85 | 2007 |
| Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells PA Knobel, IN Kotov, E Felley-Bosco, RA Stahel, TM Marti Neoplasia 13 (10), 961-IN28, 2011 | 63 | 2011 |
| Amino acid sequence of human plasma galactoglycoprotein: identity with the extracellular region of CD43 (sialophorin). K Schmid, MA Hediger, R Brossmer, JH Collins, H Haupt, T Marti, ... Proceedings of the National Academy of Sciences 89 (2), 663-667, 1992 | 55 | 1992 |
| Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma H Yang, B Sun, L Fan, W Ma, K Xu, SRR Hall, Z Wang, RA Schmid, ... Theranostics 12 (7), 3104, 2022 | 54 | 2022 |
| HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer H Yang, SQ Liang, D Xu, Z Yang, TM Marti, Y Gao, GJ Kocher, H Zhao, ... Oncogenesis 8 (9), 45, 2019 | 53 | 2019 |
| The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA. 1 phenotype GT Barut, NJ Halwe, A Taddeo, JN Kelly, J Schön, N Ebert, L Ulrich, ... Nature Communications 13 (1), 5929, 2022 | 52 | 2022 |
| mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer SQ Liang, ED Bührer, S Berezowska, TM Marti, D Xu, L Froment, H Yang, ... Oncogene 38 (5), 622-636, 2019 | 52 | 2019 |
| Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro S Zeinali, CA Bichsel, N Hobi, M Funke, TM Marti, RA Schmid, OT Guenat, ... Angiogenesis 21, 861-871, 2018 | 52 | 2018 |
| Tumor initiation capacity and therapy resistance are differential features of EMT-related subpopulations in the NSCLC cell line A549 CC Tièche, Y Gao, ED Bührer, N Hobi, SA Berezowska, K Wyler, ... Neoplasia 21 (2), 185-196, 2019 | 50 | 2019 |
| Pol η is required for DNA replication during nucleotide deprivation by hydroxyurea S De Feraudy, CL Limoli, E Giedzinski, D Karentz, TM Marti, L Feeney, ... Oncogene 26 (39), 5713-5721, 2007 | 46 | 2007 |
